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In 2001, the Meeting of the COMESA Ministers of Agriculture raised concerns that
proliferation of genetically modified organisms (GMOs) could impact significantly on
trade and food security in the region. This triggered studies on a regional approach
to biotechnology and biosafety policy in Eastern and Southern Africa. The studies
and stakeholder consultations revealed that farm incomes would increase if they
switched from conventional varieties of cotton and maize to genetically modified (GM)
counterparts. Commercial risks associated with exports to GM sensitive destinations,
e.g., EU were negligible. Intra-regional trade would be affected since exports of GM
sensitive commodities, such as maize, cotton, and soya bean, mainly go to other
African countries. These findings justified the need to consider a regional approach
to biosafety and led to the drafting of a regional policy in 2009. The draft policies
were discussed in regional and national workshops between 2010 and 2012 for wider
ownership. The workshops involved key stakeholders including ministries of agriculture,
trade, environment, national biosafety focal points, biosafety competent authorities,
academia, seed traders, millers, the media, food relief agencies, the industry, civil society,
competent authorities, and political opinion leaders. The COMESA Council of Ministers
in February 2014 adopted the COMESA policy on biotechnology and biosafety that
takes into account the sovereign right of each member state. Key provisions of the
policy include recognition of the benefits and risks associated with GMOs; establishment
of a regional-level biosafety risk-assessment system; national-level final decision, and
capacity building assistance to member states. The policies are the first regional effort
in Africa to develop a coordinated mechanism for handling biosafety issues related to
GMO use. A regional approach to biotechnology and biosafety is expected to foster
inter-country cooperation through the sharing of knowledge, expertise, experiences, and
resources.
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Background
Agriculture remains the backbone of economic development in
Africa. “Agriculture contributes approximately 35% of the con-
tinent’s GDP and accounts for 70% of its labor force” (Falck-
Zepeda et al., 2013b). Formany years, African agriculture has been
characterized by low productivity arising from little use of inputs
and reliance on rainfall. Although notable progress has beenmade
with respect to increasing productivity and availing access to
inputs, many challenges stand in the way. Climate variability is
a new reality as witnessed in erratic rainfall patterns, droughts,
and emergence of new diseases, e.g., maize lethal necrotic disease.
Rapid population increases that hover around 3% per year, and
shrinking arable land continue to constrain provision of food. Pro-
viding solutions to these and other challenges is further compli-
cated by the highly heterogeneous nature of African agro-climates,
soils, farming practices across regions and within countries.
Contemporary food price crises in 2007/2008 and 2010/2011
compounded the challenges. High and volatile food prices neg-
atively impacted food security of the vulnerable and poor, and
undermined the trade competiveness of countries. It showed that
only a few countries were self sufficient in basic food staples.
Governments in developing and emerging economies quickly
responded, especially in 2007/2008, with a myriad of policy mea-
sures that included price controls on food, cash transfers, agri-
cultural input subsidies, use of food grain stocks, export restric-
tions for grains, lower import tariffs, and increased export taxes
[ASARECA (Association for Strengthening Agricultural Research
in Eastern and Central Africa) (2008)].
While some of the policies provide important safety nets for the
vulnerable, protectionist measures can undermine trade. Trade
is particularly important in that it not only affects the avail-
ability of and access to food in the short-run but it also affects
the pace of growth of the economy as a whole. A major lesson
was that while the short-term policy responses employed were
useful in addressing immediate concerns, they were inadequate
because the high-food price volatility continues to date. Short-
term measures should be augmented with long-term measures.
Long-term measures are required to address sustained support to
the development of improved technologies and their adoption as
well asmeasures to harness the comparative advantage afforded by
regional cooperation. Such measures include harnessing science
and technology to address productivity issues, access to inputs
and knowledge and information about new technologies in the
wake of evolving challenges. These measures are enshrined in
the Malabo Declaration on accelerated agricultural growth and
transformation for shared prosperity and improved livelihoods
shared by African countries [AU (African Union) (2014)]. This
is not a new idea, but a recommitment to the Maputo declaration
of 2003 where African countries pledged to increase funding to
agriculture to at least 10% of GDP in 10 years. The countries also
adopted the principles and values of the Comprehensive Africa
Agriculture Development Program.
Further, countries in Africa have embraced regional integration
as ameans to ultimately achieving free trade in goods and services.
Key to this is adoption of common frameworks and policies as well
as sharing resources. However, regional integration can only solve
some problems. For example, trade concerns can be addressed
through improved regional integration where movement of food
is eased. On the other hand, increasing productivity requires the
development and use of more adapted high yielding varieties and
in this instance regional integration has some limited scope.
Concerns Around Biotechnology in the
Midst of Scientific Optimism in Africa
One promising, yet controversial, technological innovation is
modern biotechnology, which has both regional and national
dimensions. Biotechnology tools, including genetically modified
(GM) crops and other organisms, have produced valuable prod-
ucts that have been adopted by a large number of farmers globally
including those in Argentina, Brazil, China, and India. Africa has
not been left behind. In 2014, Africa continued to make progress
with South Africa’s land under GM crop production at 2.7 million
hectares, marginally lower than in previous seasons mainly due
to drought (James, 2014). Sudan increased Bt cotton hectarage by
almost 50%, while drought precluded a potentially higher hec-
tarage than 0.5 million hectares in Burkina Faso (James, 2014). In
addition, Cameroon, Egypt, Ghana, Kenya, Malawi, Nigeria, and
Uganda are in advanced stages of confined field trials, which are
the penultimate step prior to approval (James, 2014). Importantly,
theWater EfficientMaize for Africa project is scheduled to deliver
the first stacked biotech drought tolerantmaizewith insect control
(Bt) in South Africa in 2017 (James, 2014).
The major concerns to adoption of GM crop technology have
revolved around safety to humans and animals that would con-
sume the end products, and plants and insects in the environments
where the cropswould be grown. InAfrica, there is wide belief that
GM crops are intended for use in the industrialized countries, and
are hence inappropriate for agriculture as it is practiced in Africa
(Falck-Zepeda et al., 2013a,b). Second, with respect to trade there
are concerns that GM crops would replace conventional varieties
and thereby make farmers dependent on private seed companies.
Third, there are also concerns with existing capacities to under-
take research and effectively monitor and evaluate GM products
and their use in the continent (Mulwa et al., 2013). Finally, loss of
export markets for specific crops to trade-sensitive countries has
also been expressed. This is amplified by fears that crops approved
in one country but not another,may find their way through porous
borders and informal trade. This may not be far fetched given that
COMESA countries trade a lot with European countries where
the levels of caution and consumer skepticism are relatively high
(Paarlberg, 2008a; Wafula et al., 2012). These fears stem from
uncertainty over those who gain and those who lose from the
technology, unforeseen consequences, time before any impacts are
discovered and what would happen if there were any irreversible
damages (Omamo and von Grebmer, 2005). These fears continue
to persist in debates on GM crops. Scientists and regulators are
aware of these concerns. They address them through lengthy and
stringent biosafety regulatory phases and decision-making that
builds on stepwise accumulation of information.
A major paradox in the COMESA region is that while the
development of the regulatory frameworks has been rather slow,
scientists have made significant progress in developing various
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GMcrops, such as potato, wheat, cucumber, cotton, cassava, sweet
potato, banana, sorghum, cowpea, and rice, which are lined up
at various stages of trials (Table 1). On close inspection, the
technology has moved beyond initial focus on weed and insect
control to addressing drought tolerance, controlling bacterial and
viral diseases, and nematode infestation, improving nitrogen-use
efficiency and bio-fortification (Table 1).
The optimism shown by scientists mirrors global trends where
adoption of GM crops has been on a steep rise. In 2014, 7.1
million small scale farmers in China and 7.7 million in India
elected to plant over 15 million hectares of Bt cotton because of
the significant benefits it offers” (James, 2014). Similarly in 2014,
“415,000 small scale farmers in the Philippines benefited from
biotech maize. Biotech crop hectares were planted in 28 countries
in 2014 and hectarage has increased more than 100-fold from
1.7 million hectares in 1996 to 181.5 million hectares in 2014 –
a 6.3 million hectare increase compared to 5.0 million hectares
in 2013 at an annual growth rate of between 3 and 4%” (James,
2014).
COMESA: Toward Regional Economic
Integration
Since the launch of the COMESA Free Trade area in the year 2000,
there has been a steady increase in formal and informal intra-
COMESA trade in agricultural products [COMESA (Common
Market for Eastern and Southern Africa) (1994)] (Box 1). The
provisions of Article 129 of the COMESA Treaty stipulate full
cooperation in agricultural development, science and technology
domains, to increase agricultural production and attain regional
food security [COMESA (Common Market for Eastern and
Southern Africa) (1994)]. Further Article 130(a) of the COMESA
Treaty stipulates that “Member States undertake to co-operate
in specific fields of agriculture, including the harmonization of
agricultural policies of the Member States with a view to having
a common agricultural policy”.
One of the aims and objectives of the COMESA Treaty
(Chapter 3, Article 3a) is to co-operate in the creation of an
enabling environment for external, cross border, and domestic
investment including the joint promotion of research and adapta-
tion of science and technology for development [COMESA (Com-
mon Market for Eastern and Southern Africa) (1994)]. Chapter
18 of the Treaty encourages Member States to co-operate in the
harmonization of agricultural policies of Member States with a
view to having a common agricultural policy and the control of
animal and plant diseases and pests [COMESA (CommonMarket
for Eastern and Southern Africa) (1994)].
Development of the COMESA policy on biotechnology and
biosafety was informed in part by the recognition of the potential
for a regional framework to harness potential benefits of sci-
ence and technology and prudent regulation. The policy seeks to
ensure responsible governance of modern biotechnology in the
COMESA region. This paper reconstructs the process from the
development and eventual approval of the regional biotechnology
and biosafety policy. We describe the key elements of the Policy
and discuss the challenges and opportunities derivable from the
policy. The paper ends by identifying key lessons for similar efforts
in other regions.
TABLE 1 | Biotech/GM crops and traits that are at or beyond confined field trial stages (CFTs) in COMESA Member States.
COMESA member state Crop Trait Stage
Egypt Maize Insect resistant Commercialized in 2008, planting suspended in 2012
Potato
Wheat
Cucumber
Melon
Kenya Maize Drought tolerance CFT, fifth season
Cotton Insect resistant CFT, third season
Cassava Mosaic disease CFT, second season
Brown streak virus CFT, second season
Vitamin-A enriched CFT, second season
Sweet potato Virus disease Application for CFT
Sorghum Bio fortified (ABS) CFT, second season
Banana
Malawi Cotton Insect resistance and herbicide tolerance CFT, second season
Cowpea Insect resistance Application for CFT
Sudan Cotton Insect resistant Commercialized, third year
Uganda Maize Drought tolerance CFT, fifth season
Insect resistance CFT, first season
Banana Bacterial wilt resistance CFT, second season
Nutrition enhanced
Nematode resistance CFT, second season
Rice Nitrogen-use efficient, drought tolerance CFT, second season
Cassava Mosaic virus, brown streak virus Multi-location trials
Potato Blight resistance CFT, second season
Sweet potato Weevil resistance CFT, second season
Source: adapted from ACTESA (Alliance for Commodity Trade in Eastern and Southern Africa) (2015).
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org July 2015 | Volume 3 | Article 1093
Waithaka et al. COMESA biotechnology and biosafety policy
BOX 1 Facts about COMESA.
The Common Market for Eastern and Southern Africa (COMESA) is the largest
grouping and trading bloc in Africa in terms of area, population and number of
Member States. COMESA evolved in 1994 from the predecessor the Preferen-
tial Trade Area for Eastern and Southern Africa, which had been established
in 1982 with the aim of forming an economic community in the region.
The Member States are: Burundi, Comoros, Democratic Republic of Congo,
Djibouti, Egypt, Eritrea, Ethiopia, Kenya, Libya, Madagascar, Malawi, Mauritius,
Rwanda, Seychelles, Sudan, Swaziland, Uganda, Zambia, and Zimbabwe. The
19 COMESAMember States represent over 440 million people, $32 billion/year
in imports, and $82 billion/year in exports (Azzarri et al., 2014). The average
growth rate of the gross domestic product was 6.6 % in 2013 (COMESA,
2014b). In 2014, the annual import bill was US$170 billion while the export
bill was US$112 billion (COMESA, 2014b).
The design of COMESA aimed to remove the structural and institutional
weaknesses in the Member States by strengthening collective action especially
in pooling of resources to sustain development efforts. Since 2008, COMESA
has been working together with the East African Community and the Southern
Africa Development Community towards a Tripartite Free Trade Area Agreement
that will bring together 26Member States. This expandedmarket holds promise
of benefits of economies of scale and complementarities.
Problem Statement and Justification
Half of the projected increase in global populations by 2050 will
occur in Sub-Saharan Africa. Population growth is expected to
drive increases in demand for food, feed, and fiber. It is projected
that agricultural food demand to 2050 will rise by 50% (Tilman
et al., 2001) while demand for animal feeds will increase by 84%
by 2020 (Delgado et al., 1999). To meet this demand, options for
enhancing yields include expansion of the area under cropland
at the expense of other ecosystems, increasing yields on existing
croplands and or reallocating current agricultural production to
more productive uses (Licker et al., 2010).
In the past two decades, cereal yields have shown consis-
tent increase across Africa, from 1,159 kg/ha during 1990–1995
to 1,448 kg/ha during the 2003–2012 period (Bahiigwa et al.,
2014). Cereal yields have increased most in eastern and southern
Africa and least in northern Africa. The highest yields in the
2003–2012 period were reported in the COMESA region, with
1,780 kg/ha, followed by EAC with 1,627 kg/ha (Bahiigwa et al.,
2014). Although, yields have gone up, the yield gap remains
substantial. Globally, the yield gap for wheat and rice has been
estimated at 36% and at 50% for maize. In Africa, the yield gap
for maize is as high as 80% (Neumann et al., 2010).
Agricultural biotechnology stands out among the diverse
options available that would significantly improve crop yields
and household incomes in an environmentally sustainable way.
Trends indicate that the global adoption of the technology is
high and increasing. Developing countries mainly in Asia, Africa,
and Latin America are among the leading adopters of the tech-
nology. “By 2013, biotech cotton in countries, such as China,
India, Pakistan, Myanmar, Burkina Faso, and South Africa,
had already made a significant contribution to the income of
approximately 16.5 million poor farmers” (James, 2014). With
these developments and the increased field trials currently being
undertaken in many African countries, a regional approach to
decision-making on genetically modified organisms (GMOs) has
become a fundamental issue because of the trans-boundary nature
of GMOs (Timpo, 2011). African countries can make bigger
strides in this area by enacting functional, cost-effective and
predictable biosafety frameworks while at the same time riding
on the back of a regional framework to ease tensions between
countries.
Many studies have documented benefits accruing to farm-
ers in developing countries, who have adopted the technologies
(Mbwika, 2006; Paarlberg, 2008a,b;Mulwa et al., 2013). For exam-
ple in a study on Bt cotton welfare analysis for countries in the
COMESA region, showed that every country gained in all scenar-
ios that were considered (Mulwa et al., 2013). In the same study,
the highest gains from adopting Bt cotton would accrue to Egypt,
while Kenya had the least gains. The study showed that returns
per hectare were similar in all countries in the sub-Saharan part of
COMESA. “The distribution of gains varies between the different
categories of players in the Bt cotton industry, with most of the
gains accruing to producers and consumers while the least accrues
to innovators of the technology” (Mulwa et al., 2013).
These results are supported by a recentmeta-analysis (Klümper
and Qaim, 2014), which confirms that “the average agronomic
and economic benefits of GM crops are large and significant”.
The same analysis further showed that “yield gains and pesticide
reductions are larger for insect-resistant crops than for herbicide
tolerant crops” (Klümper and Qaim, 2014). Scientists in Africa
have been relentless in their claims that the continent stands to
gain a lot from GM technology. This is supported by analysis that
shows that yield and farmer profit gains were higher in developing
countries than those achieved in developed countries (Klümper
and Qaim, 2014). The same analysis shows an unusual finding
with respect to yields. It shows that on average, GM technology
had increased crop yields by 21%, frommore effective pest control
and thus lower crop damage and not due to higher genetic yield
potential. Despite the fact that GM seeds are more expensive
than non-GM seeds, the additional seed costs are compensated
through savings in chemical and mechanical pest control. “GM
crops reduced pesticide quantity by 37% and pesticide cost by
39%” (Klümper and Qaim, 2014). A study on the impacts to
farm incomes in Egypt, Ethiopia, Kenya, Tanzania, Uganda, and
Zambia found that average profit gains for GM-adopting farmers
were 69%” (Paarlberg et al., 2006a). These studies support the
notion that on average, adoption would be profitable. However,
it should be appreciated that results based on average measures do
not provide the true picture since they mask variability in many
conditions, such as agro-climates, host cultivars, and farming
practices (Falck-Zepeda et al., 2013a,b). This may be the reason
many policymakers and farmers inAfrica hesitate to fully embrace
GM crops. They ask for African context specific information
about the potential, benefits, costs, and safety ofGMcrops (Mulwa
et al., 2013).
However, analyzing the biosafety of specific GMOs requires
physical, human, and financial resources, which may be out of
reach for many countries in the COMESA region. Given that the
majority of COMESA Member States are yet to establish their
national biosafety regulatory frameworks, this then strengthens
the need for regional cooperation. A regional mechanism will
assist countries to share information, resources, and expertise
as they gradually build the necessary capacities for biosafety
risk assessment and develop and implement effective national
biosafety frameworks. This regional mechanism is supported by
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the Cartagena Protocol on Biosafety (CPB), which 17 out of the 19
COMESA countries are signatories to. Article 14 of the protocol
provides that countriesmay enter into bilateral, regional, andmul-
tilateral agreements and arrangements to manage trans-boundary
movement of GMOs [SCBP (Secretariat of the Convention on
Biological Diversity) (2000)].
Methodology
This paper uses a narrative approach to document and share
knowledge on the “how” around the process to eventual adoption
of the COMESA biosafety policy. Key sources of information
and data include declarations of the relevant COMESA Minis-
terial meetings, project reports and publications, proceedings of
national and regional stakeholder consultative fora on the policy
and its communication strategy, minutes of the drafting pro-
cess and related literature on biosafety issues within COMESA
Member States. This information was used to construct the story
on the process toward approval of the COMESA Biotechnology
and Biosafety Policy and to develop perspectives on challenges,
opportunities and lessons learnt.
Results and Discussion
Process to Approval of the COMESA
Biotechnology and Biosafety Policy
In the years 2001 and 2002, countries in SouthernAfrica struggled
with a severe drought where more than 15 million people faced
starvation (Omamo and von Grebmer, 2005; Paarlberg, 2008a,b).
This was not the first time this was happening. A similar situation
happened in 1991 “as a result of poor weather, policy failures, and
market failures” (Omamo and von Grebmer, 2005) Considering
that most of the maize food aid would come from countries
that had approved commercialization of GMOs, the debate on
the safety of GM based food to humans and the environment
surfaced. The reactions in 2002 were drastic. Zimbabwe, Mozam-
bique, Lesotho, and Malawi took policy decisions that limited the
import of food aid with GM content (Paarlberg, 2008a). They
placed various restrictions on imports of un-milled GM yellow
maize from the World Food Program, and Zambia refused all
GM maize even if milled. Only Swaziland continued to accept
un-milled GM maize without restriction as food aid through
the World Food Program. These developments seem to have
triggered action from the regional economic blocs. A meeting
of the Southern African Development Community council of
Ministers for Food, Agriculture and Natural Resources in July
2002 in Maputo, Mozambique noted, “the lack of a harmonized
position on GMOs was creating serious operational problems
in movement of food and non-food items” (Omamo and von
Grebmer, 2005). The COMESA Council of Ministers meeting on
November 29, 2002 in Lusaka Zambia endorsed the recommen-
dation of the meeting of Ministers of Agriculture on November 4,
2002 in Kampala, Uganda, that “COMESA should develop a com-
mon position on GMO’s and other products of biotechnology”
[COMESA (Common Market for Eastern and Southern Africa)
(2002)]. This led to the development of the Project on Regional
Approach to Biotechnology and Biosafety Policy in Eastern and
Southern Africa (RABESA). In part, RABESA was to inform and
support the move toward improved regional policy coordination
(Wafula and Waithaka, 2006).
During the first phase of the RABESA project (2004–2007),
studies were commissioned to analyze: (i) potential farm-income
gains from the adoption of GM crops; (ii) the magnitude of
commercial export risks associated with GM crops; and (iii) the
impacts of delivery of emergency food aid with GM content in the
COMESA region. The research findings were disseminated and
discussed at national consultative meetings in COMESAMember
States.
The study on farm-income gains projected that COMESA
Member States could harness substantial benefits from the adop-
tion ofGM insect-resistant varieties of cotton andmaize (Mbwika,
2006). The second study showed that use of Bt cotton for commer-
cial planting might save cotton in developing countries from boll-
worm damage and provide farmers with higher levels of income
(Paarlberg et al., 2006b). The control of bollworms is done through
application of pesticides, which is a costly exercise in terms of the
cost of pesticides, spray equipment, and labor (Mbwika, 2006).
With respect to trade-related implications of adopting GMOs
in the COMESA region, the main conclusion was that inter-
regional export losses associated with the adoption of GM crops
in the COMESA region were negligible (Paarlberg et al., 2006a).
Although COMESA countries depend heavily on the export of
agricultural products to earn foreign exchange, the major exports
were coffee, tea, sugar, horticulture, banana, and pyrethrum.None
of these crops had been commercialized anywhere in GM form,
meaning that there would be little or no GMO associated risk to
agricultural export incomes (Paarlberg et al., 2006a). The food aid
import policies study revealed that sub-Saharan Africa (SSA) was
the largest recipient of emergency food aid globally, andCOMESA
countries received 85% of all emergency food aid to SSA. About
50% of the food aid arrives as donations from countries that
are leading producers of GM crops, including USA and Canada
(Paarlberg et al., 2006b).
These findings were presented in a regional workshop that
brought together 40 key stakeholders from COMESA Member
States that was held in Nairobi in 2006 (Wafula and Waithaka,
2006). The workshop considered the three policy harmonization
options with respect to commercial planting of GMOs; com-
mercial trade policy in GM products; and policy on access to
emergency food aid with GM content. This was in line with
the aspirations of the African Union conference of agriculture
ministers in the same year, which recommended that the con-
tinental body set up mechanisms to identify commonalities and
coordinate policies on biosafety and biotechnology [AU (African
Union) (2006)]. With respect to commercial planting of GM
crops the recommendation of the workshop was for countries
to adopt a centralized regional assessment and national-level
decision-making. The advantages of this approach were that it
was standardized, transparent, cost–effective, and allowed sharing
of resources, information, and expertise. The recommendation
on commercial trade policy in GM products was for countries
to get advice/information from a central regional clearing house,
and retain decision-making at the national level. The advan-
tages of this approach were the cost-effectiveness of regional-level
assessment, cooperation in assessing trade issues, and sharing
of information and capacities. The recommendation on access
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to emergency food aid with GM content was to have guidelines
developed at regional level and national-level decision-making on
a case-by-case basis. The advantages of this approach were that
it would facilitate transit of food aid; facilitate provision of relief
food, as well as timely humanitarian response.
These recommendations were presented, discussed, and
endorsed at the fourth meeting of the COMESA Ministers of
Agriculture held in Khartoum, Sudan, in March 2007 [COMESA
(Common Market for Eastern and Southern Africa) (2007)]. The
second phase of RABESA kicked off in 2008 with two additional
partners. The International Service for the Acquisition of Agri-
biotech Applications and the Alliance for Commodity Trade in
Eastern and Southern Africa (a specialized Agency of COMESA).
In response to the Ministerial directives, the RABESA team
initiated the drafting of COMESA Regional Biosafety Policies
and Guidelines in the three priority areas: commercial planting of
GMOs, trade in GM products, and handling of emergency food
aid with GM content. A biosafety roadmap and a communication
strategy were also drafted to support the harmonization process.
These documents were presented and discussed at regional and
national consultative meetings to obtain feedback from Member
States. The draft policies and guidelines were presented and
discussed in a regional workshop that was held in April 2010 in
Nairobi, Kenya.
The recommendations from the regional workshop were pre-
sented in the third Joint meeting of the COMESA Ministers of
Agriculture, Environment and Natural Resources that was held
in July 2010, in Lusaka, Zambia. The Ministers endorsed the
biosafety roadmap and a communication strategy. They decided
that the draft policies be subjected to further national consul-
tative processes for wider ownership before they are considered
by the COMESA policy organs. Following this decision, national
consultative workshops were held in the COMESA countries
between September 2010 and September 2011. Participants in
the workshops were key stakeholders drawn from diverse insti-
tutions including ministries of agriculture, trade, environment,
national biosafety focal points, biosafety competent authorities,
seed traders, millers, the media, food relief agencies, the industry,
civil society, competent authorities, and politicians/opinion lead-
ers. A final regional validation workshop that brought together 40
participants, drawn from 15 out of the 19Member States was held
in May 2012 in Lusaka, Zambia. The participants endorsed the
policies and recommended that they be combined into one.
The validated regional biotechnology and biosafety policy was
presented, discussed, and approved at the fifth joint meeting of
theMinisters of Agriculture, Environment, andNatural Resources
that was held on 20th September 2013 in Addis Ababa, Ethiopia
[COMESA (Common Market for Eastern and Southern Africa)
(2014a)]. The policy was formally adopted by the 32nd meeting
of COMESA Council of Ministers that was held on 24th February
2014, in Kinshasa, Democratic Republic of Congo. The COMESA
biotechnology and biosafety policy is the first at the global level,
coordinated mechanism for handling biosafety issues related to
GMOs use at the regional level. The long and unwinding journey
from the start of the RABESA project to the approval of the
biosafety policy is depicted in Figure 1.
Two challenges stood in the way to the development of the
COMESA biosafety policy. The first was that most COMESA
Member States did not have functional national biosafety frame-
works. Second, countries in Southern Africa had already chal-
lenged GM technology when they declined to receive food aid
imports even when many people were faced with starvation. To
date, these effects of these challenges are still being felt. In such a
situation, then one would expect countries to have been anxious
over talks of a regional policy, fearing that they would be ceding
their sovereignty in decision-making at the national level. It is
not surprising that concerns over sovereignty often threatened
to derail the development of the regional policy. This was taken
FIGURE 1 | Long road to the approval of the regional biosafety policy.
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into consideration and the principle of national sovereignty is
recognized as the cornerstone of the COMESA Policy.
Concerns over safety and long-term impacts of GM technolo-
gies still persist. For a start, the RABESA project generated evi-
dence on potential impacts at farm level, on trade andwith respect
to food aid (Paarlberg et al., 2006a,b,c). Of the three areas, of
study, the threat of losing export markets in major destinations,
such as Europe, was a paramount issue in blocking adoption of
GM crop. This debate continues to date despite evidence from
several studies that have indicated that the magnitudes of risk
are negligible. This is mainly because COMESA countries do not
export to Europe any commodities that are currently available in
GM form.
An unforeseen challenge occurred at the COMESA level. Prior
to the year 2009, the Ministries of Agriculture handled all agricul-
tural discussions. In 2009, the sittings of Ministries of Agriculture
and those of theMinistries of Natural Resources and Environment
were combined into what was thereafter referred to as jointMinis-
terial meetings. This was welcomed in that it implied that environ-
mental concerns would also be considered alongside agricultural
issues. The downsidewas that this slowed down the process for the
biosafety policy because it necessitated more consultations with
experts from the environment department who were hitherto not
part of the GM debate.
When the second phase of RABESA started, it became imper-
ative to have more consultations with the COMESA secretariat.
This proved to be challenge and led to delays in getting some
decisions made. This was overcome when the Alliance for Com-
modity Trade in Eastern and Southern Africa (ACTESA), spe-
cialized agency of COMESA, was assigned to lead the COMESA
Biotechnology program in 2009. This shortened consultations and
decision-making and speeded-up the progress thereafter.
Key Elements of the COMESA Biotechnology and
Biosafety Policy
The regional biotechnology and biosafety policy [COMESA
(CommonMarket for Eastern and Southern Africa) (2014a)] was
designed to provide guidance and facilitate decision-making on
how to manage transboundary movement of GMOs across the
porous borders safely and responsibly. It was envisaged that a
centralized regional risk-assessment policywould allowCOMESA
countries to apply a harmonized approach to planting, trade, and
handling of emergency aid of GM crops and mitigate the antic-
ipated threat of disruption in intra-regional trade on products
containing GMOs. The approach would help foster the goal of the
COMESA Customs Union established in 2009 by the COMESA
Heads of State to promote economic integration through unre-
stricted movement of goods, services, and people. Boxes 2 and 3
present excerpts from the policy [COMESA (CommonMarket for
Eastern and SouthernAfrica) (2014a)] highlighting the objectives,
exemptions and general provisions.
Opportunities in the Implementation of the
COMESA Biotechnology and Biosafety Policy
The crops for which biotech/GM commodity products are avail-
able, within the COMESA region are banana, cassava, sorghum,
sweet potato and cotton. Those that are available outside the
BOX 2 Objectives of the policy are to:
 “provide COMESA Member States with a mechanism for scientific
regional risk assessment of GMOs intended for commercial planting,
trade and food aid in the COMESA region.”
 “provide a technical opinion about the biosafety of GMOs seeking
commercial status in the COMESA region that can be used by individual
countries to make decisions within their own national biosafety regulatory
frameworks.”
 “provide a harmonized mechanism for decision-making involving com-
mercial planting, trade of GMOs and food aid with GM content in the
COMESA region.”
 “assist COMESA Member States share and build capacity in order to
conduct scientific risk assessment and management.”
 “establish interactive regional information sharing mechanism on
biosafety and biotechnology issues in the COMESA region.”
Exemptions of the policy
 “Socio-economic, cultural, liability and redress, labeling, and other
country-specific considerations regarding GMOs will be handled at the
national level in accordance with national laws and biosafety frame-
works.”
 “Activities conducted with GMOs in the laboratories and confined field
trials, leading up to commercial planting, will be handled at the national
level in accordance with national biosafety frameworks.”
 “This policy does not imply changes in the rights and obligations of
a Member State under existing international and other regional agree-
ments.”
 “This policy does not impact or supersede other laws that apply to seeds,
food, plants or animals irrespective of whether they are GMOs (such as
general food safety legal requirements, seed variety registration, plant
quarantine, among others).”
 “The policy specifies that all topics related to biosafety not specifically
addressed within the Policy remain the responsibility of the national
biosafety frameworks of Member States.”
region are maize, soybean, cowpea and rice. These crops are
relevant and important in terms of food security and agri-business
development in the COMESA region. Their products can find
their way into the region through adoption for cultivation, formal
and informal trade, and food-aid assistance. In the short-run, this
can complicate the regulatory processwithin countries. In the long
run, without a collective regional approach, it is possible that the
GMfactormay rise to the level of trade disruption between/among
Member States as a result of different policies (Belay et al., 2014).
Therefore, focusing on uncompromised region-wide biosafety
risk-assessment instruments that are complementary to national-
level systems is important. The idea is straightforward; without
infringing on national-level decisions, for a given GM-event, if
one country conducts the risk-assessment properly it should not
necessarily be repeated in all the Member States. Given that both
biotech product testing and regulatory requirements are scientific-
knowledge and resource intensive, a regional-level biosafety risk-
assessment system will help in pooling scarce resources.
The novelty of a regional approach to biosafety considera-
tions calls for concerted efforts among key partners to ensure
success. Sustained political support is key in embracing and
operationalizing the regional biosafety policies. This can be
achieved through continuous generation of evidence-based data
for informed decision-making and implementation of a focused
communication and outreach strategy. Capacity building will be
a major requirement in ensuring that all countries have functional
biosafety systems in place while standard operating procedures
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BOX 3 General provisions on structure and procedures to implement
the policy
 “The COMESA Secretariat will establish a regional biosafety risk-
assessment desk.”
 “The COMESA Secretariat will be responsible for administration and
management of the regional risk-assessment activities (information stor-
age, sharing and exchange) in the COMESA region and liaise with
national, other regional and international bodies.” “National Competent
Authorities will be the contact focal points, and in Member States without
official competent authorities contact focal points will be identified.”
 “The COMESA Panel of Experts on Biotechnology and Biosafety (PoE)
will be the main guiding body to formulate a risk-assessment “Opinion”
on applications submitted and advice sought by Member States.”
 “The scientific risk assessments analyzed by the PoE will assess the
GMO for possible risk to human and animal health, biodiversity, and the
environment.”
 “The decision to approve or reject a GMO for commercial planting, based
on the “Opinion” from the PoE rests on the sovereign decision of the
individual COMESA Member State. COMESA, through the PoE shall
prepare the detailed standard operating procedures, including dispute
resolution, for each of the three policy areas; commercial planting of
GMOs, trade in GMOs, and emergency food aid with GM content – in
accordance with this Policy, and taking into consideration the national
biosafety frameworks of Member States.”
 “COMESA will work with Member States to establish programs dedi-
cated to creation of awareness on the existence and potential benefits
and risks of the various agricultural biotechnology applications among
stakeholders. COMESA will take the necessary steps and initiatives to
mobilize resources for continuous and strategic capacity building of
Member States with limited capacity for risk assessment and regulation
of GMOs so as to enable them competently participate in the regional
risk-assessment framework and to take informed decisions at country-
level.”
 “Member States shall enhance or put in place mechanisms for continu-
ous and regular monitoring of GMO events in their territories and keep
the COMESA Secretariat updated.”
 “Whether or not to plant GMOs, trade with GMOs, or accept food aid
with GM content will be the sovereign decision of Member States.”
and structures for implementing the policy will have to be
instituted.
Most COMESA member countries have embarked on the
development of national biosafety policies, laws and regulations.
While a few countries have progressed to more advanced stages
of developing functional biosafety systems, the majority are still
at the initial stages of development. Countries will be encour-
aged to make use of the COMESA biosafety road map as they
develop and strength their national biosafety frameworks. This
will ensure complementarity and the desired interface with the
regional biosafety decision-making arrangements.
In the long term, a regional approach to biosafety is expected
to foster inter-country cooperation through the sharing of
knowledge, expertise, experiences and resources. The COMESA
biosafety implementation plan will guide implementation of the
COMESA policy across the region. It will be the first initiative of
theCOMESA long-termprogramon biotechnology and biosafety.
Conclusion and Lesson Learnt
The pivotal provisions included in the COMESA biosafety policy
are as follows: (a) collective recognition of both the benefits and
potential risks associated with GMOs in a case-by-case approach;
(b) a regional-level and science-based biosafety risk-assessment
mechanism, coupled with national-level decision-making; and
(c) capacity building. The regional biosafety policy stands for
sharing of information, resources, and expertise, and reducing
redundancies and cost of biosafety regulations. The processes of its
formulation and approval underwent intensive consultations with
key stakeholders in an inclusive, participatory, and interactive
manner.
There have been important lessons learnt during the policy
formulation process that are still relevant when venturing into the
implementation of the policy. Key among these are that biotech-
nology/biosafety issues of regional harmonization should be han-
dled in a consultative, participatory, and inclusive manner. This
is because given the controversies that surround the technology,
the process of policy formulation was as important as the policy
framework itself. Deliberations cutting across the entire life cycle
of the RABESA project took place in 24 national and 4 regional
workshops.
Regional harmonization of biosafety policies is both a technical
and political process. It requires strong political will and commit-
ment at various levels within Member States. The progress made
and political-buy in realized so far could be attributed to the fact
that the RABESA project has been a recurrent agenda item in
various COMESA policy organ meetings. This reflects the good
will that COMESA’s highest levels maintained.
National sovereignty is a fundamental and sensitive issue. The
convergence and divergence between national and regional frame-
works had to be clearly spelled out. The pertinent concerns need to
be handled carefully to dispel fears that the regional process may
infringe on, or override national interests and decision-making
powers.
A policy on its own is insufficient to deliver desired changes to
a society unless it is implemented. Awareness and outreach efforts
need to be stepped up in order for countries to appropriate the
benefits of a regional approach in biosafety decision-making. This
necessitates the need for a focused and demand-driven commu-
nication strategy and implementation plan to ensure that credible
evidence is delivered to target audiences in the formats best suited
for them.
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